
Myovant Waits For FDA Decision, Makes Commercial Progress
ValleraTo/iStock via Getty Images Shares of Myovant Sciences (NYSE:MYOV) rose 12% since my previous article, a period during which the major indices and biotech stocks declined. However, the company made commercial and regulatory progress since […]